Long-term follow up of families with pathogenic NFKB1 variants reveals incomplete penetrance and frequent inflammatory sequelae
Nuclear factor κ light-chain enhancer of activated B cells (NF-κB) family of evolutionarily conserved transcription factors are involved in key cellular signaling pathways. Previously, hypogammaglobulinemia and common variable immunodeficiency (CVID)-like phenotypes have been associated with NFKB1 v...
Saved in:
Published in | Clinical immunology (Orlando, Fla.) Vol. 246; p. 109181 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.01.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Nuclear factor κ light-chain enhancer of activated B cells (NF-κB) family of evolutionarily conserved transcription factors are involved in key cellular signaling pathways. Previously, hypogammaglobulinemia and common variable immunodeficiency (CVID)-like phenotypes have been associated with NFKB1 variants and loss-of-function NFKB1 variants have been reported as the most common monogenic cause for CVID among Europeans. Here, we describe a Finnish cohort of NFKB1 carriers consisting of 31 living subjects in six different families carrying five distinct heterozygous variants. In contrast to previous reports, the clinical penetrance was not complete even with advancing age and the prevalence of CVID/hypogammaglobulinemia was significantly lower, whereas (auto)inflammatory manifestations were more common (42% of the total cohort). At current stage of knowledge, routine genetic screening of asymptomatic individuals is not recommended, but counseling of potential adult carriers seems necessary.
•Penetrance of NFKB1 haploinsufficiency is incomplete in screened families.•Inflammatory complications are more common than symptomatic antibody deficiency.•Routine genetic screening of all potential carriers is not recommended.•Genetic counseling of adult carriers and their parents seems imperative. |
---|---|
AbstractList | Nuclear factor κ light-chain enhancer of activated B cells (NF-κB) family of evolutionarily conserved transcription factors are involved in key cellular signaling pathways. Previously, hypogammaglobulinemia and common variable immunodeficiency (CVID)-like phenotypes have been associated with NFKB1 variants and loss-of-function NFKB1 variants have been reported as the most common monogenic cause for CVID among Europeans. Here, we describe a Finnish cohort of NFKB1 carriers consisting of 31 living subjects in six different families carrying five distinct heterozygous variants. In contrast to previous reports, the clinical penetrance was not complete even with advancing age and the prevalence of CVID/hypogammaglobulinemia was significantly lower, whereas (auto)inflammatory manifestations were more common (42% of the total cohort). At current stage of knowledge, routine genetic screening of asymptomatic individuals is not recommended, but counseling of potential adult carriers seems necessary.
•Penetrance of NFKB1 haploinsufficiency is incomplete in screened families.•Inflammatory complications are more common than symptomatic antibody deficiency.•Routine genetic screening of all potential carriers is not recommended.•Genetic counseling of adult carriers and their parents seems imperative. Nuclear factor κ light-chain enhancer of activated B cells (NF-κB) family of evolutionarily conserved transcription factors are involved in key cellular signaling pathways. Previously, hypogammaglobulinemia and common variable immunodeficiency (CVID)-like phenotypes have been associated with NFKB1 variants and loss-of-function NFKB1 variants have been reported as the most common monogenic cause for CVID among Europeans. Here, we describe a Finnish cohort of NFKB1 carriers consisting of 31 living subjects in six different families carrying five distinct heterozygous variants. In contrast to previous reports, the clinical penetrance was not complete even with advancing age and the prevalence of CVID/hypogammaglobulinemia was significantly lower, whereas (auto)inflammatory manifestations were more common (42% of the total cohort). At current stage of knowledge, routine genetic screening of asymptomatic individuals is not recommended, but counseling of potential adult carriers seems necessary. Nuclear factor κ light-chain enhancer of activated B cells (NF-κB) family of evolutionarily conserved transcription factors are involved in key cellular signaling pathways. Previously, hypogammaglobulinemia and common variable immunodeficiency (CVID)-like phenotypes have been associated with NFKB1 variants and loss-of-function NFKB1 variants have been reported as the most common monogenic cause for CVID among Europeans. Here, we describe a Finnish cohort of NFKB1 carriers consisting of 31 living subjects in six different families carrying five distinct heterozygous variants. In contrast to previous reports, the clinical penetrance was not complete even with advancing age and the prevalence of CVID/hypogammaglobulinemia was significantly lower, whereas (auto)inflammatory manifestations were more common (42% of the total cohort). At current stage of knowledge, routine genetic screening of asymptomatic individuals is not recommended, but counseling of potential adult carriers seems necessary.Nuclear factor κ light-chain enhancer of activated B cells (NF-κB) family of evolutionarily conserved transcription factors are involved in key cellular signaling pathways. Previously, hypogammaglobulinemia and common variable immunodeficiency (CVID)-like phenotypes have been associated with NFKB1 variants and loss-of-function NFKB1 variants have been reported as the most common monogenic cause for CVID among Europeans. Here, we describe a Finnish cohort of NFKB1 carriers consisting of 31 living subjects in six different families carrying five distinct heterozygous variants. In contrast to previous reports, the clinical penetrance was not complete even with advancing age and the prevalence of CVID/hypogammaglobulinemia was significantly lower, whereas (auto)inflammatory manifestations were more common (42% of the total cohort). At current stage of knowledge, routine genetic screening of asymptomatic individuals is not recommended, but counseling of potential adult carriers seems necessary. |
ArticleNumber | 109181 |
Author | Seppänen, Mikko R.J. Eklund, Kari K. Kuismin, Outi Tuovinen, Elina A. Kaustio, Meri Hämäläinen, Sari Wartiovaara-Kautto, Ulla Martelius, Timi Varjosalo, Markku Soikkonen, Leila Syrjänen, Jaana Saarela, Janna Hautala, Timo Viskari, Hanna Kere, Juha |
Author_xml | – sequence: 1 givenname: Elina A. surname: Tuovinen fullname: Tuovinen, Elina A. organization: Translational Immunology Research Program, University of Helsinki, Helsinki, Finland – sequence: 2 givenname: Outi surname: Kuismin fullname: Kuismin, Outi organization: PEDEGO Research Unit, University of Oulu, Oulu, Finland – sequence: 3 givenname: Leila surname: Soikkonen fullname: Soikkonen, Leila organization: PEDEGO Research Unit, University of Oulu, Oulu, Finland – sequence: 4 givenname: Timi surname: Martelius fullname: Martelius, Timi organization: Inflammation Center, Department of Infectious Disease, Helsinki University Hospital, Helsinki, Finland – sequence: 5 givenname: Meri surname: Kaustio fullname: Kaustio, Meri organization: Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland – sequence: 6 givenname: Sari surname: Hämäläinen fullname: Hämäläinen, Sari organization: Department of Medicine, Institute of Clinical Medicine/ Internal Medicine, Kuopio University Hospital, Kuopio, Finland – sequence: 7 givenname: Hanna surname: Viskari fullname: Viskari, Hanna organization: Department of Internal Medicine, Tampere University Hospital, Tampere, Finland – sequence: 8 givenname: Jaana surname: Syrjänen fullname: Syrjänen, Jaana organization: Department of Internal Medicine, Tampere University Hospital, Tampere, Finland – sequence: 9 givenname: Ulla surname: Wartiovaara-Kautto fullname: Wartiovaara-Kautto, Ulla organization: Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland – sequence: 10 givenname: Kari K. surname: Eklund fullname: Eklund, Kari K. organization: Department of Rheumatology, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland – sequence: 11 givenname: Janna surname: Saarela fullname: Saarela, Janna organization: Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland – sequence: 12 givenname: Markku surname: Varjosalo fullname: Varjosalo, Markku organization: Systems Biology Research Group and Proteomics Unit, Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland – sequence: 13 givenname: Juha surname: Kere fullname: Kere, Juha organization: Folkhälsan Research Center, Helsinki, Finland – sequence: 14 givenname: Timo surname: Hautala fullname: Hautala, Timo organization: Research Unit of Biomedicine, University of Oulu, Oulu, Finland – sequence: 15 givenname: Mikko R.J. surname: Seppänen fullname: Seppänen, Mikko R.J. email: mikko.seppanen@hus.fi organization: Translational Immunology Research Program, University of Helsinki, Helsinki, Finland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36356849$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:152796775$$DView record from Swedish Publication Index |
BookMark | eNqFkk-PEyEYhydmjftHv4AHw9HLVGAGhjFe3I2rxkYveiYU3tmly8AItE1PfnWZtPWwh_UC5M3z8Ib3x2V15oOHqnpN8IJgwt-tF9rZcUExpaXQE0GeVReEUVJ3uGFnxzPnhJ9XlymtMcaMUv6iOm94w7ho-4vqzzL4uzpDHNEQnAs7tJlQGNCgRussJLSz-R5NKt-HO_BWo--3364J2qpolc8JRdiCcglZr8M4OciAJvCQo_IakPIGDRF-b8DnggxOjaPKIe5RmotOwcvq-VB8eHXcr6pft59-3nyplz8-f735uKw1I22u-1aYzpCeGNEYxZgC1lCjQVC90k3LKR8oX4EwHBuihCbAO9UWjmLSAOubq6o-3Jt2MG1Wcop2VHEvg7LyWHooJ5Bt2_Nu5tGB19GmbL30ISpJsGC0rJi3M_L2gEwxlMekLEebNDinPIRNkrRrmOiwELygb47oZjWC-df9lEMBxKldSCnCILXNKtvgyyStKy3lHLlcyzlyOUcuD5EXlT5ST7c_KX04SFBmvrUQZdIWSmTGRtBZmmCf1t8_0gtSfodyD7D_n_wX3hzYww |
CitedBy_id | crossref_primary_10_1016_j_jaci_2024_11_022 crossref_primary_10_1084_jem_20221105 crossref_primary_10_1371_journal_pone_0312072 crossref_primary_10_1016_j_jaip_2024_12_002 crossref_primary_10_1038_s41439_024_00271_2 crossref_primary_10_3389_fped_2024_1386959 crossref_primary_10_1016_j_xcrm_2024_101503 crossref_primary_10_1080_1744666X_2023_2174105 crossref_primary_10_1007_s10875_024_01763_0 crossref_primary_10_1590_1806_9282_20231214 |
Cites_doi | 10.1007/s00018-013-1545-4 10.1038/ni0302-221 10.3324/haematol.2016.145136 10.1016/j.jaci.2016.10.054 10.1016/j.clim.2018.07.015 10.1007/s10875-013-9924-z 10.1016/j.ajhg.2015.07.008 10.1016/j.jaci.2019.11.051 10.1016/j.cell.2016.12.012 10.1038/nri.2017.52 10.3389/fimmu.2021.621503 10.1146/annurev.immunol.021908.132641 10.1016/j.jaci.2018.01.039 10.1101/gad.183434.111 10.1038/sigtrans.2017.23 10.3389/fimmu.2019.02618 |
ContentType | Journal Article |
Copyright | 2022 The Authors Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. info:eu-repo/semantics/openAccess |
Copyright_xml | – notice: 2022 The Authors – notice: Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. – notice: info:eu-repo/semantics/openAccess |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 3HK ADTPV AOWAS D8T ZZAVC |
DOI | 10.1016/j.clim.2022.109181 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic NORA - Norwegian Open Research Archives SwePub SwePub Articles SWEPUB Freely available online SwePub Articles full text |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1521-7035 |
ExternalDocumentID | oai_swepub_ki_se_449679 10852_100649 36356849 10_1016_j_clim_2022_109181 S1521661622002625 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29B 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABPPZ ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CJTIS COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HX~ HZ~ IH2 IHE J1W K-O KOM L7B LG5 LUGTX M41 MO0 N9A O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SDP SES SEW SPCBC SSH SSZ T5K X7M XPP Y6R Z5R ZGI ZMT ~G- 6I. AACTN AAFTH AFCTW AFKWA AJOXV AMFUW RIG SSI AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 08R 3HK AAIAV AALMO AAPBV AAUGY ABLVK ABPIF ABPTK ABQIS ABYKQ AJBFU EFJIC LCYCR ZA5 ADTPV AOWAS D8T ZZAVC |
ID | FETCH-LOGICAL-c514t-948d7d191d83da55ae532dce82cbc34626f26be8d60d1a8c1e67a455a2013e593 |
IEDL.DBID | .~1 |
ISSN | 1521-6616 1521-7035 |
IngestDate | Mon Aug 25 03:39:58 EDT 2025 Sat Apr 29 05:44:24 EDT 2023 Mon Jul 21 09:17:25 EDT 2025 Wed Feb 19 02:25:02 EST 2025 Tue Jul 01 02:44:09 EDT 2025 Thu Apr 24 23:01:24 EDT 2025 Tue Dec 03 03:44:27 EST 2024 Tue Aug 26 16:33:41 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | NF-κB CVID Common variable immunodeficiency Autoinflammation WBC anti-PnP Hypogammaglobulinemia ERCP Inborn errors of immunity IEI NFKB1 |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c514t-948d7d191d83da55ae532dce82cbc34626f26be8d60d1a8c1e67a455a2013e593 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 NFR/187615 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1521661622002625 |
PMID | 36356849 |
PQID | 2735870886 |
PQPubID | 23479 |
ParticipantIDs | swepub_primary_oai_swepub_ki_se_449679 cristin_nora_10852_100649 proquest_miscellaneous_2735870886 pubmed_primary_36356849 crossref_citationtrail_10_1016_j_clim_2022_109181 crossref_primary_10_1016_j_clim_2022_109181 elsevier_sciencedirect_doi_10_1016_j_clim_2022_109181 elsevier_clinicalkey_doi_10_1016_j_clim_2022_109181 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2023 2023-01-00 20230101 2023 |
PublicationDateYYYYMMDD | 2023-01-01 |
PublicationDate_xml | – month: 01 year: 2023 text: January 2023 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Clinical immunology (Orlando, Fla.) |
PublicationTitleAlternate | Clin Immunol |
PublicationYear | 2023 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Gasparini, Celeghini, Monasta, Zauli (bb0035) 2014; 71 Karin, Lin (bb0010) 2002; 3 Liu, Zhang, Joo, Sun (bb0030) 2017; 2 Schröder, Sogkas, Fliegauf, Dörk, Liu, Hanitsch (bb0085) 2019; 10 Tuijnenburg, Lango Allen, Burns, Greene, Jansen, Staples (bb0065) 2018; 142 Maffucci, Filion, Boisson, Itan, Shang, Casanova (bb0080) 2016 Vallabhapurapu, Karin (bb0015) 2009; 27 Karin (bb0040) 2009 Kaustio, Haapaniemi, Göös, Hautala, Park, Syrjänen (bb0055) 2017; 140 Zhang, Lenardo, Baltimore (bb0020) 2017; 168 Yoshioka, Nishikomori, Hara, Okada, Hashii, Okafuji (bb0025) 2013; 33 Fliegauf, V, Frede, Slade, Woon, Lehnert (bb0075) 2015; 97 Li, Lei, Zhang, Rapaport, Seeleuthner, Lyu (bb0060) 2021 Dieli-Crimi, Martínez-Gallo, Franco-Jarava, Antolin, Blasco, Paramonov (bb0090) 2018; 195 Ameratunga, Ahn, Steele, Woon (bb0100) 2019 Hayden, Ghosh (bb0005) 2012; 26 Sun (bb0045) 2017; 17 Lorenzini, Fliegauf, Klammer, Frede, Proietti, Bulashevska (bb0070) 2020; 146 Schipp, Nabhani, Bienemann, Simanovsky, Kfir-Erenfeld, Assayag-Asherie (bb0095) 2016; 101 Fliegauf, Krüger, Steiner, Hanitsch, Büchel, Wahn (bb0050) 2021; 12 Yoshioka (10.1016/j.clim.2022.109181_bb0025) 2013; 33 Kaustio (10.1016/j.clim.2022.109181_bb0055) 2017; 140 Karin (10.1016/j.clim.2022.109181_bb0010) 2002; 3 Zhang (10.1016/j.clim.2022.109181_bb0020) 2017; 168 Lorenzini (10.1016/j.clim.2022.109181_bb0070) 2020; 146 Dieli-Crimi (10.1016/j.clim.2022.109181_bb0090) 2018; 195 Hayden (10.1016/j.clim.2022.109181_bb0005) 2012; 26 Fliegauf (10.1016/j.clim.2022.109181_bb0050) 2021; 12 Fliegauf (10.1016/j.clim.2022.109181_bb0075) 2015; 97 Gasparini (10.1016/j.clim.2022.109181_bb0035) 2014; 71 Ameratunga (10.1016/j.clim.2022.109181_bb0100) 2019 Tuijnenburg (10.1016/j.clim.2022.109181_bb0065) 2018; 142 Maffucci (10.1016/j.clim.2022.109181_bb0080) 2016 Schröder (10.1016/j.clim.2022.109181_bb0085) 2019; 10 Vallabhapurapu (10.1016/j.clim.2022.109181_bb0015) 2009; 27 Karin (10.1016/j.clim.2022.109181_bb0040) 2009 Li (10.1016/j.clim.2022.109181_bb0060) 2021 Liu (10.1016/j.clim.2022.109181_bb0030) 2017; 2 Sun (10.1016/j.clim.2022.109181_bb0045) 2017; 17 Schipp (10.1016/j.clim.2022.109181_bb0095) 2016; 101 |
References_xml | – volume: 168 start-page: 37 year: 2017 end-page: 57 ident: bb0020 article-title: 30 years of NF-κB: a blossoming of relevance to human pathobiology publication-title: Cell – volume: 17 start-page: 545 year: 2017 end-page: 558 ident: bb0045 article-title: The non-canonical NF-κB pathway in immunity and inflammation publication-title: Nat. Rev. Immunol. – volume: 33 start-page: 1165 year: 2013 end-page: 1174 ident: bb0025 article-title: Autosomal dominant anhidrotic ectodermal dysplasia with immunodeficiency caused by a novel NFKBIA mutation, p.Ser36Tyr, presents with mild ectodermal dysplasia and non-infectious systemic inflammation publication-title: J. Clin. Immunol. – start-page: 7 year: 2016 ident: bb0080 article-title: Genetic diagnosis using whole exome sequencing in common variable immunodeficiency publication-title: Front. Immunol. – start-page: 1 year: 2009 ident: bb0040 article-title: NF-κB as a Critical Link between Inflammation and Cancer – volume: 142 start-page: 1285 year: 2018 end-page: 1296 ident: bb0065 article-title: Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans publication-title: J. Allergy Clin. Immunol. – volume: 71 start-page: 2083 year: 2014 end-page: 2102 ident: bb0035 article-title: NF-κB pathways in hematological malignancies publication-title: Cell. Mol. Life Sci. – volume: 2 start-page: 17023 year: 2017 ident: bb0030 article-title: NF-κB signaling in inflammation publication-title: Signal Transduct. Target Ther. – volume: 3 start-page: 221 year: 2002 end-page: 227 ident: bb0010 article-title: NF-κB at the crossroads of life and death publication-title: Nat. Immunol. – start-page: 218 year: 2021 ident: bb0060 article-title: Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency publication-title: J. Exp. Med. – volume: 10 start-page: 2618 year: 2019 ident: bb0085 article-title: Late-onset antibody deficiency due to Monoallelic alterations in NFKB1 publication-title: Front. Immunol. – volume: 101 start-page: e392 year: 2016 end-page: e396 ident: bb0095 article-title: Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans publication-title: Haematologica – volume: 27 start-page: 693 year: 2009 end-page: 733 ident: bb0015 article-title: Regulation and function of NF-κB transcription factors in the immune system publication-title: Annu. Rev. Immunol. – volume: 140 start-page: 782 year: 2017 end-page: 796 ident: bb0055 article-title: Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes publication-title: J. Allergy Clin. Immunol. – volume: 97 start-page: 389 year: 2015 end-page: 403 ident: bb0075 article-title: Haploinsufficiency of the NF-κB1 subunit p50 in common variable immunodeficiency publication-title: Am. J. Hum. Genet. – volume: 195 start-page: 49 year: 2018 end-page: 58 ident: bb0090 article-title: Th1-skewed profile and excessive production of proinflammatory cytokines in a NFKB1-deficient patient with CVID and severe gastrointestinal manifestations publication-title: Clin. Immunol. – volume: 12 start-page: 1327 year: 2021 ident: bb0050 article-title: A pathogenic missense variant in NFKB1 causes common variable immunodeficiency due to detrimental protein damage publication-title: Front. Immunol. – start-page: 10 year: 2019 ident: bb0100 article-title: The natural history of untreated primary Hypogammaglobulinemia in adults: implications for the diagnosis and treatment of common variable immunodeficiency disorders (CVID) publication-title: Front. Immunol. – volume: 26 start-page: 203 year: 2012 end-page: 234 ident: bb0005 article-title: NF-κB, the first quarter-century: remarkable progress and outstanding questions publication-title: Genes Dev. – volume: 146 start-page: 901 year: 2020 end-page: 911 ident: bb0070 article-title: Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations publication-title: J. Allergy Clin. Immunol. – start-page: 10 year: 2019 ident: 10.1016/j.clim.2022.109181_bb0100 article-title: The natural history of untreated primary Hypogammaglobulinemia in adults: implications for the diagnosis and treatment of common variable immunodeficiency disorders (CVID) publication-title: Front. Immunol. – volume: 71 start-page: 2083 year: 2014 ident: 10.1016/j.clim.2022.109181_bb0035 article-title: NF-κB pathways in hematological malignancies publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-013-1545-4 – volume: 3 start-page: 221 year: 2002 ident: 10.1016/j.clim.2022.109181_bb0010 article-title: NF-κB at the crossroads of life and death publication-title: Nat. Immunol. doi: 10.1038/ni0302-221 – volume: 101 start-page: e392 year: 2016 ident: 10.1016/j.clim.2022.109181_bb0095 article-title: Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans publication-title: Haematologica doi: 10.3324/haematol.2016.145136 – volume: 140 start-page: 782 year: 2017 ident: 10.1016/j.clim.2022.109181_bb0055 article-title: Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2016.10.054 – volume: 195 start-page: 49 year: 2018 ident: 10.1016/j.clim.2022.109181_bb0090 article-title: Th1-skewed profile and excessive production of proinflammatory cytokines in a NFKB1-deficient patient with CVID and severe gastrointestinal manifestations publication-title: Clin. Immunol. doi: 10.1016/j.clim.2018.07.015 – start-page: 1 year: 2009 ident: 10.1016/j.clim.2022.109181_bb0040 – volume: 33 start-page: 1165 year: 2013 ident: 10.1016/j.clim.2022.109181_bb0025 article-title: Autosomal dominant anhidrotic ectodermal dysplasia with immunodeficiency caused by a novel NFKBIA mutation, p.Ser36Tyr, presents with mild ectodermal dysplasia and non-infectious systemic inflammation publication-title: J. Clin. Immunol. doi: 10.1007/s10875-013-9924-z – start-page: 218 year: 2021 ident: 10.1016/j.clim.2022.109181_bb0060 article-title: Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency publication-title: J. Exp. Med. – volume: 97 start-page: 389 year: 2015 ident: 10.1016/j.clim.2022.109181_bb0075 article-title: Haploinsufficiency of the NF-κB1 subunit p50 in common variable immunodeficiency publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2015.07.008 – volume: 146 start-page: 901 year: 2020 ident: 10.1016/j.clim.2022.109181_bb0070 article-title: Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2019.11.051 – volume: 168 start-page: 37 year: 2017 ident: 10.1016/j.clim.2022.109181_bb0020 article-title: 30 years of NF-κB: a blossoming of relevance to human pathobiology publication-title: Cell doi: 10.1016/j.cell.2016.12.012 – volume: 17 start-page: 545 year: 2017 ident: 10.1016/j.clim.2022.109181_bb0045 article-title: The non-canonical NF-κB pathway in immunity and inflammation publication-title: Nat. Rev. Immunol. doi: 10.1038/nri.2017.52 – volume: 12 start-page: 1327 year: 2021 ident: 10.1016/j.clim.2022.109181_bb0050 article-title: A pathogenic missense variant in NFKB1 causes common variable immunodeficiency due to detrimental protein damage publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.621503 – start-page: 7 year: 2016 ident: 10.1016/j.clim.2022.109181_bb0080 article-title: Genetic diagnosis using whole exome sequencing in common variable immunodeficiency publication-title: Front. Immunol. – volume: 27 start-page: 693 year: 2009 ident: 10.1016/j.clim.2022.109181_bb0015 article-title: Regulation and function of NF-κB transcription factors in the immune system publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.021908.132641 – volume: 142 start-page: 1285 year: 2018 ident: 10.1016/j.clim.2022.109181_bb0065 article-title: Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2018.01.039 – volume: 26 start-page: 203 year: 2012 ident: 10.1016/j.clim.2022.109181_bb0005 article-title: NF-κB, the first quarter-century: remarkable progress and outstanding questions publication-title: Genes Dev. doi: 10.1101/gad.183434.111 – volume: 2 start-page: 17023 year: 2017 ident: 10.1016/j.clim.2022.109181_bb0030 article-title: NF-κB signaling in inflammation publication-title: Signal Transduct. Target Ther. doi: 10.1038/sigtrans.2017.23 – volume: 10 start-page: 2618 year: 2019 ident: 10.1016/j.clim.2022.109181_bb0085 article-title: Late-onset antibody deficiency due to Monoallelic alterations in NFKB1 publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.02618 |
SSID | ssj0005226 |
Score | 2.441678 |
Snippet | Nuclear factor κ light-chain enhancer of activated B cells (NF-κB) family of evolutionarily conserved transcription factors are involved in key cellular... |
SourceID | swepub cristin proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 109181 |
SubjectTerms | Agammaglobulinemia Autoinflammation Common variable immunodeficiency Common Variable Immunodeficiency - genetics Follow-Up Studies Humans Hypogammaglobulinemia Immunologic Deficiency Syndromes - genetics Inborn errors of immunity NF-kappa B - genetics NF-kappa B p50 Subunit - genetics NFKB1 |
Title | Long-term follow up of families with pathogenic NFKB1 variants reveals incomplete penetrance and frequent inflammatory sequelae |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1521661622002625 https://dx.doi.org/10.1016/j.clim.2022.109181 https://www.ncbi.nlm.nih.gov/pubmed/36356849 https://www.proquest.com/docview/2735870886 http://hdl.handle.net/10852/100649 http://kipublications.ki.se/Default.aspx?queryparsed=id:152796775 |
Volume | 246 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqViAuqLzDozIS4oLCbhzbsY-lYrVQuheo1Jvl2A5aWJJVycKN_vXOOM6KhygSt2x2HFme8TzsmW8Ieeaa4AKrirxwfppzp-tcOQ-yPK2lqK2f1hUWCp8s5PyUvz0TZzvkaKyFwbTKpPsHnR61dXozSas5WS-Xk_doecC6SIZ5BuDGYwU7r1DKX_74Oc0jtlxD4hypU-HMkOPlVkusRmcMUZUKxLa-5uLeav9mpv50Q3_DGI12abZPbiaHkh4Oc75FdkJ7m1w_SVfmd8jFu679mKMCpg3wvPtON2vaNTSebECYTPEklmJj4g5kaenoYnb8qqDfIIbGFBmKEE8gohRRHBBJuA90Dfqxx4YcgdrW0-Y8pmP3QNKAfH2J9_Y05mivbLhLTmevPxzN89R1IXfgPPW55spXHsI4r0pvhbBBlMy7oJirXckhAGqYrIPycuoLq1wRZGU50DE8URW6vEd2264NDwjVFQNvQjlbWc29wOjOKt3AB6pGe11kJEvLbVoQeAQrFQxRlCXXGSlGBhiX4Mqxa8bKjHlpnwyyzyD7zMC-jLzYjlkPYB1XUpcjX81YhgqK04AtuXKU2I76RVD_Oe7pKDoGdjBey9g2dJuvBhxIAVpTKZmR-4NMbWdfInygwtV4PgjZ9h-EBU-vPsNTMJxrWemH_zm9R-QG_CqHw6XHZLc_34Qn4G719UHcTwdk7_DN8XxxCdYVKUk |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEY8L4lUITyMhLijdjWMn9hEqVgvd3Qut1Jvl2E61sCSrkm1v8NeZcZwVD1EkblEyjizPeB72zDeEvLS1t56VWZpZN065VVUqrQNZHleFqIwbVyUWCs8XxfSYfzgRJzvkYKiFwbTKqPt7nR60dXwziqs5Wi-Xo49oecC6FAzzDMCNv0Kucti-2MZg_9vPeR6h5xpSp0geK2f6JC-7WmI5OmMIq5QhuPU1GzZX8zc79acf-hvIaDBMk9vkVvQo6Zt-0nfIjm_ukuvzeGd-j3yftc1pihqY1sD09oJu1rStaTjagDiZ4lEsxc7ELQjT0tLF5PBtRs8hiMYcGYoYTyCjFGEcEEq483QNCrLDjhyemsbR-izkY3dAUoOAfQkX9zQkaa-Mv0-OJ--ODqZpbLuQWvCeulRx6UoHcZyTuTNCGC9y5qyXzFY25xAB1ayovHTF2GVG2swXpeFAx_BIVah8j-w2beMfEqpKBu6EtKY0ijuB4Z2RqoYflLVyKktIEpdbNyDxiFYqGMIoF1wlJBsYoG3EK8e2GSs9JKZ90sg-jezTPfsS8no7Zt2jdVxKnQ981UMdKmhODcbk0lFiO-oXSf3nuBeD6GjYwngvYxrfbr5q8CAFqE0pi4Q86GVqO_sc8QMlrsarXsi2XxAXPL76DE9ec66KUj36z-k9JzemR_OZnr1fHD4mN-FL3p80PSG73dnGPwXfq6uehb31A180Ktc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+follow+up+of+families+with+pathogenic+NFKB1+variants+reveals+incomplete+penetrance+and+frequent+inflammatory+sequelae&rft.jtitle=Clinical+immunology+%28Orlando%2C+Fla.%29&rft.au=Tuovinen%2C+EA&rft.au=Kuismin%2C+O&rft.au=Soikkonen%2C+L&rft.au=Martelius%2C+T&rft.date=2023&rft.issn=1521-6616&rft.volume=246&rft.spage=109181&rft_id=info:doi/10.1016%2Fj.clim.2022.109181&rft.externalDocID=oai_swepub_ki_se_449679 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1521-6616&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1521-6616&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1521-6616&client=summon |